FRI059 Long-term Follow-up On Partial Lipodystrophy Treated With Leptin Receptor Agonist Mibavademab(REGN4461)

Disclosure: M.C. Foss de Freitas: Advisory Board Member; Self; PTC Therapeutics. A. DillGomes: None. A. Neidert: None. S. Podgrabinska: Employee; Self; Regeneron Pharmaceuticals. B. Olenchock: Employee; Self; Regeneron Pharmaceuticals. R. SinhaRoy: Employee; Self; Regeneron Pharmaceuticals. C.A. Har...

Descripción completa

Detalles Bibliográficos
Autores principales: Foss de Freitas, Maria Cristina, DillGomes, Anabela, Neidert, Adam, Podgrabinska, Simona, Olenchock, Ben, SinhaRoy, Rababir, Harris, Charles Andrew, Akinci, Baris, Altarejos, Judith, Oral, Elif A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Adipose Tissue, Appetite, & Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553525/
http://dx.doi.org/10.1210/jendso/bvad114.070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553525/
http://dx.doi.org/10.1210/jendso/bvad114.070

Ejemplares similares